Swedish Biotech Breakthroughs

Biovica International

Market Cap: SEK 98.4m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Ascelia Pharma

Market Cap: SEK 402.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Initiator Pharma

Market Cap: SEK 200.6m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Xspray Pharma

Market Cap: SEK 1.3b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 5.0m

Develops drugs for lipid related diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.9b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

SynAct Pharma

Market Cap: SEK 1.3b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Active Biotech

Market Cap: SEK 118.6m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Diamyd Medical

Market Cap: SEK 1.4b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Guard Therapeutics International

Market Cap: SEK 28.2m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.